Stedman Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
- Paid Up Capital ₹ 1.25 Cr
- Company Age 39 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 18.21 Cr
- Satisfied Charges ₹ 3.51 Cr
- Revenue Growth 5.42%
- Profit Growth -100.49%
- Ebitda -11.55%
- Net Worth 2.34%
- Total Assets 3.11%
About Stedman Pharmaceuticals
Stedman Pharmaceuticals Private Limited (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 26 December 1985 and has a history of 39 years and one month. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.25 Cr.
The company currently has active open charges totaling ₹18.21 Cr. The company has closed loans amounting to ₹3.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajagopal Rangachari and Ramkumar Rajagopal serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231TN1985PTC012518
- Company No.
012518
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Dec 1985
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
What products or services does Stedman Pharmaceuticals Private Limited offer?
Stedman Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Antiseptic Mouthwashes, Steel & Stainless Steel Products, Stainless Steel Products, Anti Infective Agent, Hand Sanitizer & Disinfectant, Alcohol Based Hand Sanitizer, Antipyretic Medication, Paracetamol Suspension, Swimming Pool Chemicals.
Who are the key members and board of directors at Stedman Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramkumar Rajagopal  | Managing Director | 02-Sep-2002 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajagopal Rangachari | Director | 01-Jan-1986 | Current |
Financial Performance of Stedman Pharmaceuticals.
Stedman Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.42% increase. The company also saw a substantial fall in profitability, with a 100.49% decrease in profit. The company's net worth moved up by a moderate rise of 2.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stedman Pharmaceuticals?
In 2023, Stedman Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Anabond Stedman Pharma Research Private LimitedRajagopal Rangachari and Ramkumar Rajagopal are mutual person
Charges (Loans)
₹18.21 Cr
₹3.51 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 18.21 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Feb 2003 | State Bank Of India | ₹18.21 Cr | Open |
| 03 Jan 2001 | The Tamilnadu Industrial Invesment Corporation Ltd | ₹7.36 M | Satisfied |
| 18 Sep 2000 | State Bank Of India | ₹1.19 M | Satisfied |
| 21 Jun 1999 | The Tamilnadu Industrial Investment Corporation Ltd | ₹0.87 M | Satisfied |
| 09 Apr 1999 | State Bank Of India | ₹1.10 Cr | Satisfied |
How Many Employees Work at Stedman Pharmaceuticals?
Stedman Pharmaceuticals has a workforce of 482 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stedman Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stedman Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
